1. Home
  2. LXU vs DBVT Comparison

LXU vs DBVT Comparison

Compare LXU & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$14.82

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.94

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
DBVT
Founded
1968
2002
Country
United States
France
Employees
513
90
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
LXU
DBVT
Price
$14.82
$20.94
Analyst Decision
Hold
Buy
Analyst Count
4
7
Target Price
$14.63
$32.04
AVG Volume (30 Days)
1.5M
228.8K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
225.93
10.26
EPS
0.34
N/A
Revenue
$615,208,000.00
$5,636,000.00
Revenue This Year
$13.69
$35.04
Revenue Next Year
N/A
$2,360.78
P/E Ratio
$42.91
N/A
Revenue Growth
17.77
35.77
52 Week Low
$5.86
$7.53
52 Week High
$17.22
$26.19

Technical Indicators

Market Signals
Indicator
LXU
DBVT
Relative Strength Index (RSI) 54.48 51.02
Support Level $7.92 $20.23
Resistance Level $15.66 $23.52
Average True Range (ATR) 0.74 0.89
MACD -0.05 -0.05
Stochastic Oscillator 76.22 41.41

Price Performance

Historical Comparison
LXU
DBVT

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: